Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
17 August 2022 | Story Edzani Nephalela and Coreen Steenkamp | Photo Francois van Vuuren
Academic Leadership Programme
The new cohort of the Academic Leadership Programme.

Educational leaders serve a significant administrative, management, and leadership function in higher education. A departmental chair’s role differs fundamentally from other leadership contexts, based on the momentous transition from being an academic by profession to providing leadership at departmental level.
The Academic Leadership Programme (APL) was launched by the University of the Free State (UFS) Centre for Teaching and Learning (CTL) to equip academics for various managerial positions. Faculty deans propose candidates for this programme; the second cohort has been chosen as the first is nearing completion. 
The first workshop commenced with an engagement with the Rector and Vice-Chancellor of the UFS, Prof Francis Petersen, and the Vice-Rector: Academic, Dr Engela van Staden, who both shared strategic academic leadership perspectives during the orientation and welcoming of the APL. 
Such reflections highlighted the expectations of being an educator, the complexity, and the critical role of departmental chairs within higher education institutions. Academic leaders are thus expected to establish firm leadership within their departments, facilitate intellectual development, manage administrative duties, and strive toward resilient learning and teaching environments. 
“The position of departmental chairs remains critical for any higher education institution, as they provide leadership in advancing the discipline, teaching students, producing quality graduates, and serving the professional community,” said Prof Francois Strydom, Senior Director: Centre for Teaching and Learning.
Research confirms that most academics succeed in these roles without formal leadership training, yet the expectation of developing or having certain leadership qualities or management competencies must fulfil the various functions of such a position. 


News Archive

Collaboration between UFS and Mayo Clinic to revolutionise cancer treatment
2014-06-27



Attending the lecture were, from the left: Dr Chantel Swart, Prof Lodewyk Kock, Prof Debabrata Mukhopadhyay, Prof James du Preez; back: Prof Pieter van Wyk.
Dr Swart, Profs Kock and Du Preez are from the Department of Microbial, Biochemical and Food Biotechnology. Prof Mukhopadhyay is from the Mayo Clinic (US) and Prof Van Wyk is from the Centre for Microscopy at the UFS.
Photo: Supplied
The UFS made a discovery that may have enormous implications for the treatment of diseases in humans.

Since the discovery, the UFS joined forces with the Mayo Clinic in Rochester, US, in the fight against cancer.

In this collective effort, UFS researchers would be able to assist the Mayo team to:
• see how treatment in cancer patients is progressing,
• target treatments more effectively,
• reduce dosages in order to make treatment gentler on the patient,
• track the effectiveness of the chemotherapy drugs used, and
• gain an accurate view of how the cancer is being eliminated.

Prof Lodewyk Kock, Outstanding Professor at the Department of Microbial, Biochemical and Food Biotechnology, and his team incidentally created a technique to use argon gas particles for the first time on biological material to slice open cells to look inside.

The team that supported Prof Kock includes Dr Chantel Swart, Khumisho Dithebe (PhD student), Prof Hendrik Swart (Department of Physics) and Prof Pieter van Wyk (Centre for Microscopy).

Prof Debabrata Mukhopadhyay from the Mayo Clinic in Rochester, US, got to hear about this breakthrough at the UFS and a collaboration between the two institutions was established.

During a visit to the Bloemfontein Campus, Prof Mukhopadhyay explained novel techniques that make use of gold nanoparticles. These particles attach to chemotherapeutic drugs to selectively target cancer cells – dramatically decreasing the side effects to normal human cells.

For these new drugs (coupled to gold nanoparticles) to be accepted into clinical practice, visual and chemical proof is needed, though. This is where the technique developed by the UFS will play a vital role.

With the technique to look inside cells, the composition, location and metabolism of these drugs can be determined. This will aid in a proof of concept for the application of the nano-drugs. Furthermore, it will enable approval for use of these drugs in clinical trials and eventually could revolutionise cancer treatment as a whole.

For video lectures on the technique used, as well as its findings, follow these links:

1. http://vimeo.com/63643628 (Comic version for school kids)

2. http://vimeo.com/61521401 (Detailed version for fellow scientists)

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept